Suven Pharmaceuticals Limited (SUVENPHAR) — Cash Flow Quality Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Cash Flow Quality Index of 0.55x as of December 2023. Operating cash flow of Rs255.04 Million is below net income of Rs467.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SUVENPHAR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Suven Pharmaceuticals Limited Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Suven Pharmaceuticals Limited across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Suven Pharmaceuticals Limited.
Annual Cash Flow Quality Index for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year earnings quality comparison for Suven Pharmaceuticals Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | Rs2.88 Billion | Rs3.44 Billion | ▼ -29.8% |
| 2024 | 1.19x | Rs3.58 Billion | Rs3.00 Billion | ▲ +48.2% |
| 2023 | 0.81x | Rs4.51 Billion | Rs5.60 Billion | ▲ +63.0% |
| 2022 | 0.49x | Rs3.30 Billion | Rs6.68 Billion | ▼ -39.7% |
| 2021 | 0.82x | Rs3.83 Billion | Rs4.68 Billion | ▼ -20.3% |
| 2020 | 1.03x | Rs4.16 Billion | Rs4.05 Billion | ▲ +222.1% |
| 2019 | 0.32x | Rs504.05 Million | Rs1.58 Billion | — |